Big Pharma’s Patent Abuses Are Fueling the Drug Pricing Crisis
The latest in news from I-MAK experts.
For press inquiries, please contact simon@i-mak.org.
India Rejects Abbott’s Patent Application for Lifesaving HIV Drug
India Rejects Abbot Lab’s Patent Application for HIV Drug
India Rejects Abbott Lab’s Patent Application for HIV Drug
Global HIV Patients Get India Boost vs Abbott
India Rejects Sham Patent Application for Life-saving Drug
Patent Office Rejects Abbott Labs Plea for Expensive AIDS Drug
Life Saving Move! India Rejects Abbott’s HIV drug patent
Abbott’s HIV Drug Patent Plea Rejected for Lack of Novelty
Abbott’s Patent Plea for HIV Drug Rejected
Patent Office Rejects Abbot’s Application on HIV Drug